Clinical trial
Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of…
NCT00298779 · Millennium Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00298779 |
|---|---|
| Title | Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma. |
| Official title | An Open-Label Study to Assess the Effect of Omeprazole Administration on the Pharmacokinetics of VELCADE in Subjects With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma |
| Lead sponsor | Millennium Pharmaceuticals, Inc., Industry |
| Collaborators | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumors, Non-Hodgkins's Lymphoma |
| Intervention type | Drug |
| Interventions | omeprazole and bortezomib |
| Enrollment | 20 |
| First posted | Mar 3, 2006 |
| Last update posted | Jun 6, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: